Alan Meds

What it is

Patients take an eligibility quiz and online visit; prescriptions come from independent physician networks.

It lists compounded semaglutide, tirzepatide, oral and microdose GLP-1s, plus brand-name Wegovy, Zepbound, Ozempic and Mounjaro.

It also sells hair, skin, menopause and longevity treatments.

Alan's wellness and longevity line includes NAD+ injection, nasal spray, patches and face cream, glutathione injection, nasal spray and patches, and sermorelin.

NAD+ injection is listed from $235/month, paid upfront on a 2-month plan; NAD+ nasal spray from $125/month; glutathione injection from $155/month.

The program is self-pay and does not require insurance.

The site says compounded medications are not FDA-approved.

Prescribes: Mostly compounded semaglutide, tirzepatide and liraglutide; brand-name Wegovy, Zepbound, Ozempic, Mounjaro also listed Compounded NAD+, glutathione and sermorelin (not FDA-approved), plus GLP-1s.

What it costs

Insurance: Site says no insurance needed

Prices change often. Check alanmeds.com before you sign up.

By the numbers

• Trustpilot 3.8/5 from 595 reviews (only 19 reviews in the last 12 months; company replied to 18% of negative reviews; checked 2026-10-15).4

Pros and cons

What users say

Common themes in public posts on Reddit, Trustpilot, the Better Business Bureau and app stores, summarised and linked. Individual experiences vary.

• Recent reviewers report unanswered calls and emails and difficulty reaching support3
• Some reviewers describe billing after cancellation attempts and shipping delays3
• Positive reviews credit specific staff and treatment results3
• Alan Meds gets very little Reddit discussion; a June 2025 post warns of vague responses when trying to cancel a monthly membership.5
• Recent Trustpilot reviews describe being unable to reach support by phone, email or chat, missing shipments, charges after cancelling, and some reviewers wondering whether the company is still operating normally; older reviews praise specific staff and results.4
• Positive reviews credit named staff and the check-ins during the program.3
• Many recent reviewers report unreachable phone/email support, delayed or paused shipments, renewals after attempted cancellation and some fear the company is closing; none seen mention NAD+.3

Records we found

Official and court records we found in public sources as of October 15, 2026. This is not a live or complete record; check fda.gov, ftc.gov and court sites for the latest.

1. Feb 2026
   FDA

   FDA sent a warning letter stating that labels naming Alan implied it was the compounder of its compounded semaglutide and tirzepatide, rendering the products misbranded under sections 502(a) and 502(bb) of the FD&C Act.1

2. Feb 2026
   FDA

   FDA warning letter stating labels naming Alan implied it was the compounder of its compounded semaglutide and tirzepatide (not about NAD+).1